Skip to main content
. 2023 Mar 13;15(5):1652–1667. doi: 10.18632/aging.204581

Figure 7.

Figure 7

Schematic diagram summarizes the mechanisms by which ANGPTL2 facilitates lymphangiogenesis in human lung cancer cells. ANGPTL2 increases VEGF-A production and subsequently facilitates LEC lymphangiogenesis in human lung cancer cells via the integrin α5β1 receptor, p38 and NF-κB signaling.